A century of BCG: Impact on tuberculosis control and beyond.

Ahmed, Asma; Rakshit, Srabanti; Adiga, Vasista; Dias, Mary; Dwarkanath, Pratibha; D'Souza, George; Vyakarnam, Annapurna

Ahmed, Asma; Rakshit, Srabanti; Adiga, Vasista; Dias, Mary; Dwarkanath, Pratibha; D'Souza, George; Vyakarnam, Annapurna.

Afiliação

Ahmed A; Laboratory of Immunology of HIV-TB co-infection, Centre for Infectious Disease Research, Indian Institute of Science, Bangalore, India.
Rakshit S; Laboratory of Immunology of HIV-TB co-infection, Centre for Infectious Disease Research, Indian Institute of Science, Bangalore, India.
Adiga V; Laboratory of Immunology of HIV-TB co-infection, Centre for Infectious Disease Research, Indian Institute of Science, Bangalore, India.
Dias M; Division of Infectious Diseases, St John's Research Institute, Bangalore, India.
Dwarkanath P; Division of Nutrition, St John's Research Institute, Bangalore, India.
D'Souza G; Division of Infectious Diseases, St John's Research Institute, Bangalore, India.
Vyakarnam A; Department of Pulmonary Medicine, St John's Medical College, Bangalore, India.

Immunol Rev ; 301(1): 98-121, 2021 05.

Article em En | MEDLINE | ID: mdl-33955564

Assuntos

Vacina BCG/imunologia; Mycobacterium tuberculosis/imunologia; Tuberculose/imunologia; Tuberculose/prevenção & controle; Vacinação; Imunidade Adaptativa; Vacina BCG/administração & dosagem; Humanos; Imunidade Heteróloga; Imunidade Inata; Imunogenicidade da Vacina; Memória Imunológica

Palavras-chave

BCG; TB; adaptive; innate; revaccination; trained immunity; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Vacina BCG / Vacinação / Mycobacterium tuberculosis Limite: Humans Idioma: En Revista: Immunol Rev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google